Morgan Stanley
ZSAN

Morgan Stanley’s Zosano Pharma Corporation ZSAN Stock Holding History

Morgan Stanley’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,399
Closed -$27K – 8306
2022
Q1 		$27K Buy
3,399
+1,289
+61% +$14.2K ﹤0.01% 7019
2021
Q4 		$34K Buy
2,110
+1,045
+98% +$22.1K ﹤0.01% 6990
2021
Q3 		$27K Hold
1,065
– – ﹤0.01% 6985
2021
Q2 		$35K Sell
1,065
-246
-19% -$7.93K ﹤0.01% 6810
2021
Q1 		$57K Buy
1,311
+1,187
+957% +$49.7K ﹤0.01% 6300
2020
Q4 		$2K Sell
124
-36,056
-100% -$705K ﹤0.01% 6917
2020
Q3 		$2.05M Buy
36,180
+35,885
+12,164% +$1.67M ﹤0.01% 3634
2020
Q2 		$9K Sell
295
-39
-12% -$1.1K ﹤0.01% 6200
2020
Q1 		$7K Buy
334
+77
+30% +$2.58K ﹤0.01% 6134
2019
Q4 		$14K Buy
+257
New +$15.9K ﹤0.01% 6193
2019
Q2 		– Sell
-7,679
Closed -$1.28M – 6827
2019
Q1 		$1.28M Buy
7,679
+2,111
+38% +$259K ﹤0.01% 3943
2018
Q4 		$413K Hold
5,568
– – ﹤0.01% 4903
2018
Q3 		$797K Buy
5,568
+805
+17% +$118K ﹤0.01% 4700
2018
Q2 		$680K Buy
4,763
+3,972
+502% +$598K ﹤0.01% 4889
2018
Q1 		$139K Buy
791
+507
+179% +$170K ﹤0.01% 5615
2017
Q4 		$104K Sell
284
-57
-17% -$28.6K ﹤0.01% 5624
2017
Q3 		$196K Sell
341
-100
-23% -$73.3K ﹤0.01% 5365
2017
Q2 		$435K Buy
441
+28
+7% +$28.9K ﹤0.01% 4893
2017
Q1 		$550K Buy
+413
New +$498K ﹤0.01% 4774
2015
Q2 		– Sell
-20
Closed -$143K – 6808
2015
Q1 		$143K Buy
+20
New +$150K ﹤0.01% 5373

Other funds holding ZSAN

CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Morgan Stanley's ZSAN Position: Q2 2022 in Review

Morgan Stanley sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 3,399 shares — an estimated $27K sold.

Morgan Stanley first reported a position in ZSAN in Q1 2015 and held it in 20 quarters. The position peaked at $2.05M in Q3 2020. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

  • Morgan Stanley reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
  • Morgan Stanley sold 3,399 Zosano Pharma Corporation shares in Q2 2022, an estimated $27K.
  • Morgan Stanley first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 20 quarters.
  • Morgan Stanley's Zosano Pharma Corporation position peaked at $2.05M in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.